Kinga Półkośnik

Kinga Półkośnik

Auto-generated profile, based on publicly available information

Kinga Półkośnik

Department of Pediatrics, Gastroenterology, Hepatology, Nutrition, Allergology and Pulmonology, Medical University of Białystok, Białystok, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Medical Science Monitor
Verified
Journal Article
Open access
KTKinga Trochimczyk
Kinga Trochimczyk
MFMarta Flisiak-Jackiewicz
Marta Flisiak-Jackiewicz
ABAnna Bobrus-Chociej
Anna Bobrus-Chociej
ALAnna Lebensztejn
Anna Lebensztejn
MWMałgorzata Wojtkowska
Małgorzata Wojtkowska
DLDariusz Marek Lebensztejn
Dariusz Marek Lebensztejn
Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease - Article abstract #943375

24 August 2023 in Medical Science Monitor
Verified
Journal Article
Open access
KZKatarzyna Zdanowicz
Katarzyna Zdanowicz
DLDawid Lewandowski
Dawid Lewandowski
PMPiotr Majewski
Piotr Majewski
KPKinga Półkośnik
Kinga Półkośnik
NLNikolina Liwoch-Nienartowicz
Nikolina Liwoch-Nienartowicz
Kacper ToczylowskiKacper Toczylowski
Kacper Toczylowski
Background: Respiratory tract infections (RTIs) in children often involve a complex interplay between viruses and bacteria. This study aimed to evaluate clinical presentation in children under 5 years old diagnosed with non-COVID-19 bacterial and viral respiratory tract co-infections between October 2021 and May 2022 in Bialystok, Poland. Material/Methods: We recruited 100 children under 5 years with RTIs who tested negative for SARS-CoV-2. Nasopharyngeal swabs were screened for 19 viruses and 7 bacterial strains using molecular assays. Results: Viral pathogens were detected in 71% of patients and bacterial pathogens were detected in 59%. The most common pathogens were Haemophilus influenzae (n=48), rhinoviruses (n=32), and Streptococcus pneumoniae (n=30). Single pathogens were detected in 36%, dual in 37%, triple in 15%, and quadruple in 2%. Bacterial pathogens were co-detected with viruses in 40 cases, mostly with rhinoviruses (n=15). Two different viruses were found in 14 children and the most common co-detection was adenovirus with rhinovirus (n=5); dyspnea (63% vs 11%) and wheezing (75% vs 22%) were more common in children with human bocavirus. Fever was a common symptom in children with human adenovirus (88% vs 58%). Detection of bacteria and multiple detections were more common in day-care attendees, but were not associated with clinical picture of RTI.Conclusions: Consistent with previous studies, we found a high prevalence of rhinoviruses, despite ongoing implementation of non-pharmaceutical interventions to contain the COVID-19 pandemic. Co-detection of 2 different respiratory pathogens was frequent, but we found no evidence that this was associated with the severity of infections.

21 June 2023 in Medical Science Monitor
Verified
Journal Article
Open access
KPKinga Półkośnik
Kinga Półkośnik
AŁAgnieszka Łebkowska
Agnieszka Łebkowska
IKIrina Kowalska
Irina Kowalska
DLDariusz M. Lebensztejn
Dariusz M. Lebensztejn
With the expanding understanding of conditions contributing to heightened cardiovascular risk, emerging pathologies like nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) are being recognized as hepatic and ovarian manifestations of metabolic syndrome, respectively. This study aims to elucidate the recent advancements in our comprehension of the link between these conditions in the pediatric demographic, focusing on pathogenesis, incidence, diagnostic methods, and effective therapeutic strategies. A systematic review was conducted by searching the PubMed database for eligible original studies published in the 10-year period prior to January 2023 (2013–2022). Out of 23 reports based on 16 original studies, we found a significantly higher prevalence of NAFLD in adolescents with PCOS compared to healthy controls. Factors such as increased de novo lipogenesis, alterations in gut microbiota, and a deficiency in growth differentiation factor-15 have been implicated in their pathogenesis. Additionally, novel biomarker S100A4, a clinical prediction score for hepatic steatosis in PCOS, and pharmacotherapy involving low-dose spironolactone, pioglitazone, and metformin have been proposed to enhance the management of these conditions. A meticulous approach to the prevention, detection, and treatment of NAFLD in adolescents with PCOS is paramount to mitigate further complications. The study underlines the need for ongoing research to refine our understanding and management of these interconnected metabolic disorders.